140 related articles for article (PubMed ID: 32228887)
1. NUDT21 suppresses the growth of small cell lung cancer by modulating GLS1 splicing.
Gao CC; Xu QQ; Xiao FJ; Wang H; Wu CT; Wang LS
Biochem Biophys Res Commun; 2020 May; 526(2):431-438. PubMed ID: 32228887
[TBL] [Abstract][Full Text] [Related]
2. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor β1 alters the 3'-UTR of mRNA to promote lung fibrosis.
Ko J; Mills T; Huang J; Chen NY; Mertens TCJ; Collum SD; Lee G; Xiang Y; Han L; Zhou Y; Lee CG; Elias JA; Jyothula SSK; Rajagopal K; Karmouty-Quintana H; Blackburn MR
J Biol Chem; 2019 Oct; 294(43):15781-15794. PubMed ID: 31488543
[TBL] [Abstract][Full Text] [Related]
4. NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1.
Jonnakuti VS; Ji P; Gao Y; Lin A; Chu Y; Elrod N; Huang KL; Li W; Yalamanchili HK; Wagner EJ
J Neurooncol; 2023 Jul; 163(3):623-634. PubMed ID: 37389756
[TBL] [Abstract][Full Text] [Related]
5. LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation.
Zhang N; Liu X; Huang L; Zeng J; Ma C; Han L; Li W; Yu J; Yang M
Cell Rep; 2023 Dec; 42(12):113479. PubMed ID: 37999979
[TBL] [Abstract][Full Text] [Related]
6. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
Tan S; Li H; Zhang W; Shao Y; Liu Y; Guan H; Wu J; Kang Y; Zhao J; Yu Q; Gu Y; Ding K; Zhang M; Qian W; Zhu Y; Cai H; Chen C; Lobie PE; Zhao X; Sun J; Zhu T
Oncogene; 2018 Aug; 37(35):4887-4900. PubMed ID: 29780166
[TBL] [Abstract][Full Text] [Related]
7. NUDT21 regulates 3'-UTR length and microRNA-mediated gene silencing in hepatocellular carcinoma.
Sun M; Ding J; Li D; Yang G; Cheng Z; Zhu Q
Cancer Lett; 2017 Dec; 410():158-168. PubMed ID: 28964783
[TBL] [Abstract][Full Text] [Related]
8. NUDT21 knockdown inhibits proliferation and promotes apoptosis of pancreatic ductal adenocarcinoma through EIF2 signaling.
Zheng YS; Chen ML; Lei WD; Zhu SL; You XQ; Liu Y
Exp Cell Res; 2020 Oct; 395(2):112182. PubMed ID: 32707135
[TBL] [Abstract][Full Text] [Related]
9. NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.
Xiong M; Chen L; Zhou L; Ding Y; Kazobinka G; Chen Z; Hou T
Theranostics; 2019; 9(24):7156-7167. PubMed ID: 31695759
[No Abstract] [Full Text] [Related]
10. The role of NUDT21 in microRNA-binging sites of EZH2 gene increases the of risk preeclampsia.
Lang X; Zhao W; Huang D; Liu W; Shen H; Xu L; Xu S; Huang Y; Cheng W
J Cell Mol Med; 2019 May; 23(5):3202-3213. PubMed ID: 30883033
[TBL] [Abstract][Full Text] [Related]
11. Myc-induced glutaminolysis bypasses HIF-driven glycolysis in hypoxic small cell lung carcinoma cells.
Munksgaard Thorén M; Vaapil M; Staaf J; Planck M; Johansson ME; Mohlin S; Påhlman S
Oncotarget; 2017 Jul; 8(30):48983-48995. PubMed ID: 28430666
[TBL] [Abstract][Full Text] [Related]
12. Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.
Chu Y; Elrod N; Wang C; Li L; Chen T; Routh A; Xia Z; Li W; Wagner EJ; Ji P
Oncogene; 2019 May; 38(21):4154-4168. PubMed ID: 30705404
[TBL] [Abstract][Full Text] [Related]
13. Nudt21 Controls Cell Fate by Connecting Alternative Polyadenylation to Chromatin Signaling.
Brumbaugh J; Di Stefano B; Wang X; Borkent M; Forouzmand E; Clowers KJ; Ji F; Schwarz BA; Kalocsay M; Elledge SJ; Chen Y; Sadreyev RI; Gygi SP; Hu G; Shi Y; Hochedlinger K
Cell; 2018 Jan; 172(1-2):106-120.e21. PubMed ID: 29249356
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of NUDT21 contributes to cervical cancer progression through alternative polyadenylation.
Xing Y; Chen L; Gu H; Yang C; Zhao J; Chen Z; Xiong M; Kazobinka G; Liu Y; Hou T
Oncogene; 2021 Mar; 40(11):2051-2064. PubMed ID: 33619322
[TBL] [Abstract][Full Text] [Related]
15. Alternative polyadenylation reprogramming of MORC2 induced by NUDT21 loss promotes KIRC carcinogenesis.
Tan Y; Zheng T; Su Z; Chen M; Chen S; Zhang R; Wang R; Li K; Na N
JCI Insight; 2023 Sep; 8(18):. PubMed ID: 37737260
[TBL] [Abstract][Full Text] [Related]
16. CFIm25 regulates glutaminase alternative terminal exon definition to modulate miR-23 function.
Masamha CP; Xia Z; Peart N; Collum S; Li W; Wagner EJ; Shyu AB
RNA; 2016 Jun; 22(6):830-8. PubMed ID: 27095025
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2.
Gao F; Wu H; Wang R; Guo Y; Zhang Z; Wang T; Zhang G; Liu C; Liu J
Bioengineered; 2019 Dec; 10(1):1-12. PubMed ID: 30836864
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2.
Zhao Z; Liu J; Wang C; Wang Y; Jiang Y; Guo M
Int J Clin Exp Pathol; 2014; 7(11):7726-34. PubMed ID: 25550809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]